Feasibility of Telaprevir-Based Triple Therapy in Liver Transplant Patients with Hepatitis C Virus: SVR 24 Results

Management of recurrent Hepatitis C virus (HCV) infection following liver transplantation remains a major challenge. In non-transplanted HCV genotype 1 patients, the introduction of protease inhibitor-based regimens has significantly increased the rate of sustained virological response. In this foll...

Descripción completa

Detalles Bibliográficos
Autores principales: Werner, Christoph R., Egetemeyr, Daniel P., Lauer, Ulrich M., Nadalin, Silvio, Königsrainer, Alfred, Malek, Nisar P., Berg, Christoph P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3827217/
https://www.ncbi.nlm.nih.gov/pubmed/24265827
http://dx.doi.org/10.1371/journal.pone.0080528

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3827217/
https://www.ncbi.nlm.nih.gov/pubmed/24265827
http://dx.doi.org/10.1371/journal.pone.0080528

Ejemplares similares